{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:35:43Z","timestamp":1767414943873},"reference-count":34,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.regpep.2004.04.029","type":"journal-article","created":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T22:24:08Z","timestamp":1089757448000},"page":"201-207","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532)"],"prefix":"10.1016","volume":"123","author":[{"given":"Yuki","family":"Ohmori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Onoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Kashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2004.04.029_BIB1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.regpep.2004.04.029_BIB2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02740606","article-title":"VIP: molecular biology and neurobiological function","volume":"3","author":"Gozes","year":"1989","journal-title":"Mol. Neurobiol"},{"key":"10.1016\/j.regpep.2004.04.029_BIB3","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1210\/endo.135.6.7988457","article-title":"Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions","volume":"135","author":"Usdin","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2004.04.029_BIB4","first-page":"265","article-title":"International union of pharmacology: XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide","volume":"50","author":"Harmar","year":"1998","journal-title":"Pharmacol. Rev"},{"key":"10.1016\/j.regpep.2004.04.029_BIB5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/87887","article-title":"Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease","volume":"7","author":"Delgado","year":"2001","journal-title":"Nat. Med"},{"key":"10.1016\/j.regpep.2004.04.029_BIB6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1381612013398374","article-title":"Immunology of VIP: a review and therapeutical perspectives","volume":"7","author":"Gomariz","year":"2001","journal-title":"Curr. Pharm. Des"},{"key":"10.1016\/j.regpep.2004.04.029_BIB7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/pupt.2001.0306","article-title":"Vasoactive intestinal polypeptide as mediator of asthma","volume":"14","author":"Groneberg","year":"2001","journal-title":"Pulm. Pharmacol. Ther"},{"key":"10.1016\/j.regpep.2004.04.029_BIB8","first-page":"269","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"Vaudry","year":"2000","journal-title":"Pharmacol. Rev"},{"key":"10.1016\/j.regpep.2004.04.029_BIB9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00210505","article-title":"Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects","volume":"220","author":"Dey","year":"1981","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.regpep.2004.04.029_BIB10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00494059","article-title":"VIP like immunoreactive nerves in human respiratory tract. Light and electron microscopy study","volume":"82","author":"Laitinen","year":"1985","journal-title":"Histochemistry"},{"key":"10.1016\/j.regpep.2004.04.029_BIB11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJM198905113201904","article-title":"Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma","volume":"320","author":"Ollerenshaw","year":"1989","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.regpep.2004.04.029_BIB12","first-page":"1282","article-title":"Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist: Part I. In vitro and in vivo bronchodilator studies","volume":"270","author":"O'Donnell","year":"1994","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.regpep.2004.04.029_BIB13","first-page":"1289","article-title":"Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agosnit: Part II. Effect on in vitro and in vivo models of pulmonary anaphylaxis","volume":"270","author":"O'Donnell","year":"1994","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.regpep.2004.04.029_BIB14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/thorax.58.3.217","article-title":"Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma","volume":"58","author":"Lind\u00e9n","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.regpep.2004.04.029_BIB15","series-title":"Proceedings of the 39th Japanese Peptide Symposium Kobe","first-page":"301","article-title":"Development of a new vasoactive intestinal peptide analogue and its topical administration system, dry powder inhalation","author":"Endo","year":"2002"},{"key":"10.1016\/j.regpep.2004.04.029_BIB16","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/endo-114-5-1506","article-title":"Characterization and localization of vasoactive intestinal peptide receptor in the rat lung","volume":"114","author":"Leroux","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2004.04.029_BIB17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.regpep.2004.04.029_BIB18","first-page":"176","article-title":"Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment","volume":"215","author":"Yamada","year":"1980","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.regpep.2004.04.029_BIB19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0003-2697(67)90297-7","article-title":"A graphic method for the determination and presentation of binding parameters in a complex system","volume":"20","author":"Rosenthal","year":"1967","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.regpep.2004.04.029_BIB20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0304-4165(81)90049-0","article-title":"Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes","volume":"678","author":"Robberecht","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.regpep.2004.04.029_BIB21","first-page":"249","article-title":"Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung","volume":"239","author":"Carstairs","year":"1986","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.regpep.2004.04.029_BIB22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0196-9781(88)90270-7","article-title":"Pharmacological characterization of VIP receptors in human lung membrane","volume":"9","author":"Robberecht","year":"1988","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2004.04.029_BIB23","doi-asserted-by":"crossref","first-page":"19363","DOI":"10.1016\/S0021-9258(19)77642-X","article-title":"Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors","volume":"263","author":"Patthi","year":"1988","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.regpep.2004.04.029_BIB24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.lfs.2003.07.048","article-title":"Structure\u2013activity relationship of synthetic truncated analogues of vasoactive intestinal peptide (VIP): an enhancement in the activity by a substitution with arginine","volume":"74","author":"Onoue","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2004.04.029_BIB25","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/S0024-3205(99)00507-X","article-title":"Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotrophin-releasing hormone (TRH) analogue","volume":"65","author":"Urayama","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2004.04.029_BIB26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0024-3205(01)01445-X","article-title":"Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues","volume":"70","author":"Urayama","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2004.04.029_BIB27","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1164\/ajrccm.161.5.9903102","article-title":"Asthma. From bronchoconstriction to airways inflammation and remodeling","volume":"161","author":"Bousquet","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.regpep.2004.04.029_BIB28","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.4049\/jimmunol.150.12.5281","article-title":"Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements","volume":"150","author":"Nio","year":"1993","journal-title":"J. Immunol"},{"key":"10.1016\/j.regpep.2004.04.029_BIB29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(83)90012-2","article-title":"Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung","volume":"88","author":"Undem","year":"1983","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.regpep.2004.04.029_BIB30","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.4049\/jimmunol.142.10.3533","article-title":"Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage","volume":"142","author":"O'Dorisio","year":"1989","journal-title":"J. Immunol"},{"key":"10.1016\/j.regpep.2004.04.029_BIB31","first-page":"L151","article-title":"Vasoactive intestinal peptide prevents lung injury due to xanthine\/xanthine oxidase","volume":"259","author":"Berisha","year":"1990","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.regpep.2004.04.029_BIB32","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1016\/S0021-9258(18)55404-1","article-title":"Vasoactive intestinal peptide, a singlet oxygen quencher","volume":"265","author":"Misra","year":"1990","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.regpep.2004.04.029_BIB33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/arrd.1984.130.2.162","article-title":"The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans","volume":"130","author":"Barnes","year":"1984","journal-title":"Am. Rev. Respir. Dis"},{"key":"10.1016\/j.regpep.2004.04.029_BIB34","first-page":"427","article-title":"Pretreatment of exercise-induced asthma with inhaled vasoactive intestinal peptide (VIP)","volume":"128","author":"Bundgaard","year":"1983","journal-title":"Eur. J. Respir. Dis., Suppl"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011504001685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011504001685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:05:17Z","timestamp":1682726717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011504001685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":34,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0167011504001685"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2004.04.029","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}